These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 16728546

  • 1. Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency.
    Luczay A, Török D, Ferenczi A, Majnik J, Sólyom J, Fekete G.
    Eur J Endocrinol; 2006 Jun; 154(6):859-64. PubMed ID: 16728546
    [Abstract] [Full Text] [Related]

  • 2. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB, Turatti W, Elias PC, Elias LL, Martinelli CE, Moreira AC, Antonini SR, de Castro M.
    Gene; 2013 Sep 10; 526(2):239-45. PubMed ID: 23570880
    [Abstract] [Full Text] [Related]

  • 3. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran.
    Vakili R, Baradaran-Heravi A, Barid-Fatehi B, Gholamin M, Ghaemi N, Abbaszadegan MR.
    Horm Res; 2005 Sep 10; 63(3):119-24. PubMed ID: 15775714
    [Abstract] [Full Text] [Related]

  • 4. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
    Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y.
    Clin Endocrinol (Oxf); 2006 Jun 10; 64(6):645-51. PubMed ID: 16712666
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
    Kelestimur F, Everest H, Dundar M, Tanriverdi F, White C, Witchel SF.
    Exp Clin Endocrinol Diabetes; 2009 May 10; 117(5):205-8. PubMed ID: 19085698
    [Abstract] [Full Text] [Related]

  • 8. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
    Schreiner F, Tozakidou M, Maslak R, Holtkamp U, Peter M, Gohlke B, Woelfle J.
    Eur J Endocrinol; 2009 Apr 10; 160(4):667-73. PubMed ID: 19174530
    [Abstract] [Full Text] [Related]

  • 9. Association between genotype, clinical presentation, and severity of congenital adrenal hyperplasia: a review.
    Al-Agha AE, Ocheltree AH, Al-Tamimi MD.
    Turk J Pediatr; 2012 Apr 10; 54(4):323-32. PubMed ID: 23692712
    [Abstract] [Full Text] [Related]

  • 10. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia.
    Ferenczi A, Garami M, Kiss E, Pék M, Sasvári-Székely M, Barta C, Staub M, Sólyom J, Fekete G.
    J Clin Endocrinol Metab; 1999 Jul 10; 84(7):2369-72. PubMed ID: 10404805
    [Abstract] [Full Text] [Related]

  • 11. [Health status of adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Bachelot A, Touraine P.
    Presse Med; 2014 Apr 10; 43(4 Pt 1):428-37. PubMed ID: 24630263
    [Abstract] [Full Text] [Related]

  • 12. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
    Guarnotta V, Niceta M, Bono M, Marchese S, Fabiano C, Indelicato S, Di Gaudio F, Garofalo P, Giordano C.
    J Steroid Biochem Mol Biol; 2020 Apr 10; 198():105554. PubMed ID: 31805392
    [Abstract] [Full Text] [Related]

  • 13. Detection and assignment of CYP21 mutations using peptide mass signature genotyping.
    Zeng X, Witchel SF, Dobrowolski SF, Moulder PV, Jarvik JW, Telmer CA.
    Mol Genet Metab; 2004 May 10; 82(1):38-47. PubMed ID: 15110320
    [Abstract] [Full Text] [Related]

  • 14. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
    de Carvalho DF, Miranda MC, Gomes LG, Madureira G, Marcondes JA, Billerbeck AE, Rodrigues AS, Presti PF, Kuperman H, Damiani D, Mendonca BB, Bachega TA.
    Eur J Endocrinol; 2016 Aug 10; 175(2):107-16. PubMed ID: 27185867
    [Abstract] [Full Text] [Related]

  • 15. Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia.
    Van de Velde H, Sermon K, De Vos A, Lissens W, Joris H, Vandervorst M, Van Steirteghem A, Liebaers I.
    Mol Hum Reprod; 1999 Jul 10; 5(7):691-6. PubMed ID: 10381826
    [Abstract] [Full Text] [Related]

  • 16. The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients.
    Di Blasio AM, van Rossum EF, Maestrini S, Berselli ME, Tagliaferri M, Podestà F, Koper JW, Liuzzi A, Lamberts SW.
    Clin Endocrinol (Oxf); 2003 Jul 10; 59(1):68-74. PubMed ID: 12807506
    [Abstract] [Full Text] [Related]

  • 17. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.
    Livadas S, Dracopoulou M, Dastamani A, Sertedaki A, Maniati-Christidi M, Magiakou AM, Kanaka-Gantenbein C, Chrousos GP, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2015 Apr 10; 82(4):543-9. PubMed ID: 25041270
    [Abstract] [Full Text] [Related]

  • 18. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Forest MG.
    Hum Reprod Update; 2004 Apr 10; 10(6):469-85. PubMed ID: 15514016
    [Abstract] [Full Text] [Related]

  • 19. An update of congenital adrenal hyperplasia.
    New MI.
    Ann N Y Acad Sci; 2004 Dec 10; 1038():14-43. PubMed ID: 15838095
    [Abstract] [Full Text] [Related]

  • 20. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo.
    Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SW.
    J Clin Endocrinol Metab; 1998 Jan 10; 83(1):144-51. PubMed ID: 9435432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.